3D Systems DDD stocks are higher.
According to Chuck Hull, 3D Systems CTO, “Over the last years as bioprinting and regenerative medicine have evolved, we’ve seen a growing need to place cells at high-resolution in a nurturing matrix to produce complex tissues. Precise 3D printing with hydrogels, followed by perfusion of cells into the printed scaffold is the best way to achieve this, and we are thankful our work with United Therapeutics has given us the opportunity to advance and perfect this technology.”
This entry was posted in 3D Printing/4D Printing /Biotechnology/Robotics., 3D/4D/5D Printing emergence/ Insights/Community Celebrations., AI Tech/Innovation/Robotics/3D Printing/Business., Policy. and tagged 3D Systems, 3D Systems DDD stocks are higher., Chuck Hull, United Therapeutics.